AbbVie Inc. (NYSE:ABBV) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, the ...

ABBV's growing oncology portfolio, now spanning five therapies, is helping offset Imbruvica's sales decline and boost ...

Myelodysplastic syndromes are haematopoietic stem cell neoplasms with characteristic dysplasia in the blood and bone marrow cells resulting in ineffective haematopoiesis, cytopenias, and increased ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The VERONA trial evaluated the safety and efficacy of venetoclax with azacitidine in treatment-naïve adults with higher-risk MDS.

Grail announced that results from the registrational PATHFINDER 2 study of its Galleri multi-cancer early detection test ...